Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Anxiety, depression, fear of cancer recurrence (FCR) and health-related quality of life (HRQL) in people with melanoma receiving adjuvant therapies.
Julia Elizabeth Lai-Kwon, Michael Jefford, Ashkan Mehrnejad, Mustafa Abdi Mohamed, Kortnye Smith, Lavinia Spain, Aparna D. Rao, Belinda Lee, George Au‐Yeung, Allison Drosdowsky, Karla Gough, Shahneen Sandhu (2025). Anxiety, depression, fear of cancer recurrence (FCR) and health-related quality of life (HRQL) in people with melanoma receiving adjuvant therapies.. , 43(16_suppl), DOI: https://doi.org/10.1200/jco.2025.43.16_suppl.9566.
Article145 days agoFinancial toxicity and employment outcomes in people with melanoma receiving adjuvant therapies.
Julia Elizabeth Lai-Kwon, Michael Jefford, Ashkan Mehrnejad, Mustafa Abdi Mohamed, Kortnye Smith, Lavinia Spain, Aparna D. Rao, Belinda Lee, George Au‐Yeung, Allison Drosdowsky, Karla Gough, Shahneen Sandhu (2025). Financial toxicity and employment outcomes in people with melanoma receiving adjuvant therapies.. , 43(16_suppl), DOI: https://doi.org/10.1200/jco.2025.43.16_suppl.9577.
Article145 days agoPatient-reported acute and chronic toxicities from adjuvant therapies post resection of melanoma.
Shahneen Sandhu, Julia Elizabeth Lai-Kwon, Ashkan Mehrnejad, Mustafa Abdi Mohamed, Kortnye Smith, Lavinia Spain, Aparna D. Rao, Belinda Lee, George Au‐Yeung, Allison Drosdowsky, Karla Gough, Michael Jefford (2025). Patient-reported acute and chronic toxicities from adjuvant therapies post resection of melanoma.. , 43(16_suppl), DOI: https://doi.org/10.1200/jco.2025.43.16_suppl.e21568.
Article145 days agoImpact of immune checkpoint inhibitors and targeted therapy on health-related quality of life of people with stage III and IV melanoma: a mixed-methods systematic review
Julia Lai‐Kwon, Andrisha–Jade Inderjeeth, Karolina Lisy, Shahneen Sandhu, Claudia Rutherford, Michael Jefford (2023). Impact of immune checkpoint inhibitors and targeted therapy on health-related quality of life of people with stage III and IV melanoma: a mixed-methods systematic review. , 184, DOI: https://doi.org/10.1016/j.ejca.2023.02.005.
Article145 days agoImpact of immune checkpoint inhibitors and targeted therapy on health-related quality of life of people with stage III and IV melanoma: a mixed-methods systematic review
Julia Lai‐Kwon, Andrisha–Jade Inderjeeth, Karolina Lisy, Shahneen Sandhu, Claudia Rutherford, Michael Jefford (2023). Impact of immune checkpoint inhibitors and targeted therapy on health-related quality of life of people with stage III and IV melanoma: a mixed-methods systematic review. , 184, DOI: https://doi.org/10.1016/j.ejca.2023.02.005.
Article145 days ago